MEPSGEN Awarded the Presidential Citation at the 2025 Venture Entrepreneurship Awards
2025-12-11
MEPSGEN partners with Sungkyunkwan University to develop glioblastoma tumor microenvironment model
2025-11-04
FDA’s Animal Testing Reform Paves the Way for MEPSGEN’s Next-Generation Organ-on-a-Chip Technology
2025-10-28
MEPSGEN and Chung-Ang University research team collaborate on joint development for stroke drug screening.
2025-10-15
MEPSGEN and Korea University Professor Chung's team agree to co-develop kidney models
2025-09-03
[Expert Column] Lab-on-a-Chip: Driving a New Revolution in Biotechnology
2025-08-19
MEPSGEN Selected for MOTIE Project on "Development of Multi-Organ Chips for Non-Clinical Drug Evaluation
2025-08-08
MEPSGEN Successfully Hosts the 2025 MEPS-X Workshop
2025-07-22
MEPSGEN Signs Research Agreement with Inha University for Joint Development of Placenta Model
2025-07-08
MEPSGEN and Karis Bio Sign MOU to Co-Develop Advanced Cardiovascular Tissue Models
2025-06-30
MEPSGEN Joins BIO USA 2025 to Expand Global Partnerships
2025-06-10
MEPSGEN partners with Cleveland Clinic to advance human gut-on-a-chip research
2025-05-28
Introducing the Next Generation of MPS Technology by MEPSGEN
2025-05-22
MEPSGEN Signs Research Agreement with KAIST Team to Develop Retinal Vascular Barrier Model
2025-05-15
[Interview] MEPSGEN's CEO warns of overlooked RNA damage risk during LNP manufacturing
2025-05-02
MEPSGEN Presents Advanced Nanoparticle Technology at LNP Summit in Boston
2025-04-17
MEPSGEN Unveils 'NanoCalibur GMP' for Preclinical and Clinical Nanoparticle Production
2025-03-13
MEPSGEN Collaborates with University of Utah for Corneal Model Research
2025-03-05
MEPSGEN and AIGEN Science Sign MOU to Advance Innovative Drug Development
2025-02-07
MEPSGEN appoints renowned MPS expert as new Chief Scientific Officer
2025-01-22
